3 Months to Total COVID Vax Trial? AMA Chief Doubts It
Finishing a segment III trial of a COVID-19 vaccine by November is an overly optimistic timeline, Susan Bailey, MD, president of the American Scientific Affiliation (AMA), acknowledged Friday. One firm started enrolling sufferers — with a goal of 30,000 of…